Biocon Limited Biocon Limited

Biocon Limited

BIOCON

Rankning i aktier #3389
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Aktiekurs
$3.75
Senast synkroniserad: 2026-10-19
Marknadsvärde
$5.13B
Förändring (1 dag)
-2.30%
Förändring (1 år)
-9.49%
Land
IN
Handel Biocon Limited (BIOCON)

Kategori

Healthcare
Utdelningsavkastning för Biocon Limited (BIOCON)
Utdelningsavkastningen (TTM) för Biocon Limited (aktiesymbol: BIOCON) per 2024-03-31 är: 0.63%
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.22%
Historik för utdelningsavkastning för Biocon Limited (BIOCON) från 2004 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
2026 (TTM) 0.14% -30.00%
2025 0.20% -68.25%
2024 0.63% 117.24%
2023 0.29% 0.00%
2022 0.00% 0.00%
2021 0.00% -100.00%
2020 0.22% 0.00%
2019 0.22% 0.00%
2018 0.22% 0.00%
2017 0.00% -100.00%
2016 2.22% 73.44%
2015 1.28% -28.89%
2014 1.80% 1.12%
2013 1.78% -7.29%
2012 1.92% 84.62%
2011 1.04% -3.70%
2010 1.08% -40.33%
2009 1.81% 151.39%
2008 0.72% 35.85%
2007 0.53% 12.77%
2006 0.47% 88.00%
2005 0.25% 0.00%
2004 0.00% 0.00%
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter
Företag Utdelningsavkastning Land
0.00%
US
0.00%
US
2.17%
AU
0.00%
CH
0.00%
NL